Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Minerva Medica
|
July 3, 2014
High-normal blood pressure and impaired renal function. A prospective study in a population-based cohort
S Bo, G Gruden, E Charbonnier, et al.
Journal of Endocrinological Investigation
|
July 2, 2008
Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction
S Bo, R Gambino, M Durazzo, et al.
Journal of Endocrinological Investigation
|
August 26, 2020
What predicts the unsuccess of bariatric surgery? An observational retrospective study
C D'Eusebio, S Boschetti, F Rahimi, et al.
Journal of Endocrinological Investigation
|
November 30, 2017
Impaired taste sensation in type 2 diabetic patients without chronic complications: a case-control study
L De Carli, R Gambino, C Lubrano, et al.
Journal of Endocrinological Investigation
|
December 24, 2005
C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia
S Bo, A Signorile, G Menato, et al.
Current Medicinal Chemistry
|
January 10, 2013
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial
S Bo, G Ciccone, A Castiglione, et al.
Diabetes & Metabolism
|
May 19, 2018
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up
V Ponzo, L Gentile, R Gambino, et al.
The Journal of Hospital Infection
|
April 3, 2009
Molecular characterisation of outbreak-related strains of vancomycin-resistant Enterococcus faecium from an intensive care unit in Beijing, China
X Zhu, B Zheng, S Wang, et al.
European Journal of Clinical Investigation
|
April 9, 2005
Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?
S Bo, R Gambino, B Uberti, et al.
Pharmacological Research
|
August 14, 2016
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
S Bo, V Ponzo, G Ciccone, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Minerva Medica
|
July 3, 2014
High-normal blood pressure and impaired renal function. A prospective study in a population-based cohort
S Bo, G Gruden, E Charbonnier, et al.
Journal of Endocrinological Investigation
|
July 2, 2008
Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction
S Bo, R Gambino, M Durazzo, et al.
Journal of Endocrinological Investigation
|
August 26, 2020
What predicts the unsuccess of bariatric surgery? An observational retrospective study
C D'Eusebio, S Boschetti, F Rahimi, et al.
Journal of Endocrinological Investigation
|
November 30, 2017
Impaired taste sensation in type 2 diabetic patients without chronic complications: a case-control study
L De Carli, R Gambino, C Lubrano, et al.
Journal of Endocrinological Investigation
|
December 24, 2005
C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia
S Bo, A Signorile, G Menato, et al.
Current Medicinal Chemistry
|
January 10, 2013
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial
S Bo, G Ciccone, A Castiglione, et al.
Diabetes & Metabolism
|
May 19, 2018
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up
V Ponzo, L Gentile, R Gambino, et al.
The Journal of Hospital Infection
|
April 3, 2009
Molecular characterisation of outbreak-related strains of vancomycin-resistant Enterococcus faecium from an intensive care unit in Beijing, China
X Zhu, B Zheng, S Wang, et al.
European Journal of Clinical Investigation
|
April 9, 2005
Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?
S Bo, R Gambino, B Uberti, et al.
Pharmacological Research
|
August 14, 2016
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
S Bo, V Ponzo, G Ciccone, et al.
Page
of 9